Active surveillance is an appropriate management strategy for a proportion of men diagnosed with prostate cancer by prostate specific antigen testing

Journal of Urology

Volumn 194, Issue 3, 2015, Pages 680-684

  Thompson, Ian M ^a   Overholser, Stephen ^a   Nielsen, Matthew ^b   Torkko, Kathleen ^c   Cwilka, Daniel ^b   Weaver, Brandi ^a   Shi, Xiaoyu ^a   Leach, Robin J ^a   Hernandez, Javier ^a   Huang, Tim ^b  

^a University of Texas Health Science Center   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

biopsy; prostate specific antigen; prostatectomy; prostatic neoplasms; watchful waiting

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACTIVE SURVEILLANCE; ADULT; AGED; ARTICLE; CANCER STAGING; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PROCEDURE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; BLOOD; CANCER GRADING; MIDDLE AGED; PATIENT SELECTION; PROSTATIC NEOPLASMS; VERY ELDERLY; WATCHFUL WAITING; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PATIENT SELECTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; WATCHFUL WAITING; YOUNG ADULT;

EID: 84938961522     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2015.01.089     Document Type: Article

References (18)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11
2. I. Thompson, J.B. Thrasher, G. Aus, et al. AUA Prostate Cancer Clinical Guideline Update Panel Guideline for the management of clinically localized prostate cancer: 2007 update J Urol 177 2007 2106
3. A. Heidenreich, J. Bellmunt, M. Bolla, and et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease Eur Urol 59 2011 61
4. J. Mohler, R.R. Bahnson, B. Boston, and et al. NCCN clinical practice guidelines in oncology: prostate cancer J Natl Compr Canc Netw 8 2010 162
5. P.A. Ganz, J.M. Barry, W. Burke, and et al. National Institutes of Health state-of-the-science conference: role of active surveillance in the management of men with localized prostate cancer Ann Intern Med 156 2012 591
6. M.R. Cooperberg, J.M. Broering, and P.R. Carroll Time trends and local variation in primary treatment of localized prostate cancer J Clin Oncol 28 2010 1117
7. N. Suardi, A. Briganti, A. Gallina, and et al. Testing the most stringent criteria for selection of candidates for active surveillance in patients with low-risk prostate cancer BJU Int 105 2010 1548
8. S.L. Conti, M. Dall'era, V. Fradet, and et al. Pathological outcomes of candidates for active surveillance of prostate cancer J Urol 181 2009 1628
9. H.B. Carter, A. Kettermann, C. Warlick, and et al. Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience J Urol 178 2007 2359
10. J.J. Tosoian, B.J. Trock, P. Landis, and et al. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience J Clin Oncol 29 2011 2185
11. L. Klotz, L. Zhang, A. Lam, and et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126
12. M.A. Dall'Era, B.R. Konety, J.E. Cowan, and et al. Active surveillance for the management of prostate cancer in a contemporary cohort Cancer 112 2008 2664
13. R.C. van den Bergh, H. Vasarainen, H.G. van der Poe, and et al. Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study BJU Int 105 2010 956
14. R.K. Berglund, T.A. Masterson, K.C. Vora, and et al. Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance J Urol 180 2008 1964
15. M.S. Soloway, C.T. Soloway, S. Williams, and et al. Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience BJU Int 101 2008 165
16. N.J. van As, A.R. Norman, K. Thomas, and et al. Predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance Eur Urol 54 2008 1297
17. M.J. Resnick, T. Koyama, K.H. Fan, and et al. Long-term functional outcomes after treatment for localized prostate cancer N Engl J Med 368 2013 436
18. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics for Hispanics/Latinos, 2012 CA Cancer J Clin 62 2012 283